Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
暂无分享，去创建一个
S. Nakamoto | H. Hanaoka | R. Muroyama | R. Nakagawa | T. Chiba | Naoya Kanogawa | S. Ogasawara | H. Tsuji | Soichiro Kiyono | T. Kondo | M. Wakatsuki | Masato Nakamura | Yohei Kawasaki | Kazufumi Kobayashi | S. Yumita | Yoshihito Ozawa | N. Kato | Keita Ogawa | Tomoko Saito | Tomoya Kurokawa | Hiroaki Kanzaki | Takamasa Ishino | Miyuki Nakagawa | K. Fujiwara | Terunao Iwanaga | T. Sakuma | K. Koroki | H. Makishima | Asahi Takahashi | N. Fujita | R. Kojima | Naoya Kato | Shingo Nakamoto